Total Artificial Heart Market Overview (2022-2032)
The global total artificial heart market was valued at around US$ 191.1Mn in 2021, registering Y-o-Y growth of 13.8%. Total artificial heart market sales are projected to increase at a healthy CAGR of 12.2% by 2032.
“The upsurge in the cardiac diseases among the population and developing healthcare infrastructure in the developing countries is anticipated to boost the market for the total artificial heart.”
Attributes
Details
Total Artificial Heart Market Value in 2021
US$ 191.9 Million
Total Artificial Heart Market Value in 2022
US$ 218.3 Million
Total Artificial Heart Market CAGR (2022 to 2032)
12.2%
A pump that is surgically placed while performing cardiac surgery is referred to as a total artificial heart. A total artificial heart is designed to provide circulation and swap cardiac ventricles. Blood is pumped from the ventricles of the heart to the lungs and other organs. The implanted pumps are managed by machines outside the body, assisting blood flow to and from the heart.
The total artificial heart works by replacing the lower chambers of the heart, known as the ventricles. The total artificial heart is connected with tubes to a power source that is out of the human body. Through the heart’s major artery, the total artificial heart then pumps blood to the lungs and the rest of the body.
The total artificial heart consists of four mechanical valves that operate like the real valves of the heart and has a vital role to maintain the blood flow. The arteries, the atrium, the aorta, and the pulmonary artery are connected to the total artificial heart with the help of these valves.
As it is connected to the right and the left atria of the heart, the functioning of a normal heart is duplicated, providing circulatory support and restoring normal blood flow across the body. After this, the total artificial heart is activated.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Major Drivers Boosting the Demand for Total Artificial Heart Market?
The primary factor driving the market growth of total artificial heart is the increasing prevalence of cardiac disorders, along with the rising healthcare awareness among the population. Additionally, rising rates of heart failure and increasing old age population are driving the growth in the market revenue.
Besides these factors, an increase in the number of hospitals and specialty centers, increased healthcare expenditure, and adoption of poor lifestyle habits are predicted to increase the growth of the total artificial heart market.
Furthermore, the introduction of various programs for spreading awareness among the population, and increasing government initiatives for the treatment of cardiac disorders are anticipated to increase the growth of the total artificial heart.
Which Region Shows Strong Growth Potential in the Total Artificial Heart Market?
North America’s total artificial heart market is expected to dominate the global market in projected years, owing to the establishment of a large number of research centers and well-developed healthcare infrastructure in this region.
Following North America, Europe is also predicted to hold a lucrative share in the total artificial heart market because of the rising prevalence of cardiac disorders. The market in East and South Asian countries like China and India is also expected to show a sustainable growth rate in near future owing to an increasing rate of heart surgeries.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Manufacturers of the Total Artificial Heart Market?
Some of the key manufacturers operating in the total artificial heart market are BiVACOR Inc., CARMAT, SynCardia Systems, LLC, ReinHeart TAH GmbH, ABIOMED, Abbott, Cirtec, LivaNova, Inc., Jarvik Heart, Inc., and CryoLife, Inc.
Report scope
Attributes
Details
Forecast Period
2022 to 2032
Historical Data Available for
2012 to 2021
Market Analysis
US$ Million for Value
By Product Type
SynCardia Systems
BiVACOR Rotary Total Artificial Heart
CARMAT
Others
By End User
Hospitals
Specialty Centers
Others
By Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Players
BiVACOR Inc.
CARMAT
SynCardia Systems, LLC
ReinHeart TAH GmbH
ABIOMED
Abbott
Cirtec
LivaNova, Inc.
Jarvik Heart, Inc.
CryoLife, Inc.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segmentation
By Product Type:
SynCardia Systems
BiVACOR Rotary Total Artificial Heart
CARMAT
Others
By End User:
Hospitals
Specialty Centers
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Frequently Asked Questions
What Is The Growth Outlook For The Global Total Artificial Heart Market?
The global total artificial heart market is anticipated to register a CAGR of 12.2% during the forecast period.
Which Are The Top 3 Companies Driving The Global Total Artificial Heart Market In 2022?
BiVACOR Inc., CARMAT, and SynCardia Systems, LLC are the top 3 companies driving the global total artificial heart market is in the year 2022.
